For the 30 percent of clinically depressed people who don’t respond to medication, the U.S. Food and Drug Administration recently approved a new, noninvasive treatment option. With NeuroStar TMS, a wand held over the head delivers highly focused magnetic pulses to a part of the brain that’s been linked to depression. A typical course of treatment would involve 40-minute sessions at a psychiatrist’s office five times a week for four to six weeks. In two clinical trials, roughly half of patients said that their symptoms were reduced by at least 50 percent.
Courtesy of Neuronetics
Product: NeuroStar TMS Therapy system
Cost: Approximately $6,000 for a course of 20 to 30 sessions, depending on the provider
Other products in this section:
Become an MIT Technology Review Insider for in-depth analysis and unparalleled perspective.Subscribe today
Subscribe to Continue Reading
Uh oh–you've read all of your free articles for this month.
Oxford Nanopore’s Hand-Held DNA Analyzer Has Traveled the World
A British company bets a hand-held analyzer will change how we look at DNA.
DNA Testing Reveals the Chance of Bad News in Your Genes
For healthy people, the value of genome sequencing is still unclear.
How Biotech Patents Are Linked to U.S. Food Productivity
What do patent databases say about how much food we’ll be able to grow? Researchers from the U.S. and France tried to find out.